Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
1.160
-0.010 (-0.85%)
Nov 21, 2024, 3:47 PM EST - Market closed
Unity Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -21.89 | -39.86 | -44.47 | -60.73 | -93.84 | -82.18 | Upgrade
|
| Depreciation & Amortization | 0.9 | 1.18 | 2.18 | 2.88 | 3.45 | 1.39 | Upgrade
|
| Other Amortization | - | 0.71 | 1.32 | 0.81 | 0.32 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.14 | -0.11 | -0.35 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 5.6 | - | - | 2.63 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.94 | -1.5 | -0.28 | 1.04 | -0.25 | -5.66 | Upgrade
|
| Stock-Based Compensation | 4.46 | 7.42 | 9.38 | 11.55 | 13.81 | 10.85 | Upgrade
|
| Other Operating Activities | -6.87 | -6.13 | -19.18 | 0.01 | 0.1 | -0.39 | Upgrade
|
| Change in Accounts Payable | 0.66 | -0.41 | -0.19 | -0.57 | -2.64 | -0.23 | Upgrade
|
| Change in Unearned Revenue | - | - | - | 0.22 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 1.3 | -3.98 | -0.83 | -0.27 | -1.91 | 3.79 | Upgrade
|
| Operating Cash Flow | -22.54 | -37.09 | -52.41 | -45.06 | -78.33 | -72.42 | Upgrade
|
| Capital Expenditures | - | -0.01 | -0.1 | -0.2 | -0.65 | -1.59 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | 0.12 | 0.38 | - | - | - | Upgrade
|
| Investment in Securities | 18.96 | 60.39 | -24.83 | 39.51 | -4.56 | 69.54 | Upgrade
|
| Investing Cash Flow | 19.1 | 60.5 | -24.55 | 39.31 | -5.21 | 67.95 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 24.55 | - | Upgrade
|
| Long-Term Debt Repaid | - | -20 | - | -0.07 | -0.05 | -0.07 | Upgrade
|
| Net Debt Issued (Repaid) | - | -20 | - | -0.07 | 24.51 | -0.07 | Upgrade
|
| Issuance of Common Stock | 4.46 | 5.22 | 58.21 | 20.91 | 39.73 | 27.51 | Upgrade
|
| Other Financing Activities | - | -1.56 | -1.97 | - | -0.36 | - | Upgrade
|
| Financing Cash Flow | 4.46 | -16.34 | 56.24 | 20.85 | 63.88 | 27.44 | Upgrade
|
| Net Cash Flow | 1.02 | 7.07 | -20.72 | 15.1 | -19.67 | 22.97 | Upgrade
|
| Free Cash Flow | -22.54 | -37.1 | -52.51 | -45.26 | -78.98 | -74.01 | Upgrade
|
| Free Cash Flow Margin | - | - | -22250.00% | -945.97% | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.36 | -2.51 | -5.53 | -8.11 | -15.53 | -16.96 | Upgrade
|
| Cash Interest Paid | - | 1.97 | 2.2 | 2.37 | 0.77 | - | Upgrade
|
| Levered Free Cash Flow | -10.16 | -20.6 | -24.73 | -21.88 | -48.19 | -44.79 | Upgrade
|
| Unlevered Free Cash Flow | -10.15 | -19.77 | -23.82 | -20.7 | -47.7 | -44.79 | Upgrade
|
| Change in Net Working Capital | -2.15 | 4.32 | 0.49 | 0.98 | 8.44 | -0.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.